Purpura, Thrombocytopenic, Idiopathic [clinicaltrials_resource:8fd5b4539415edc1fbd6361e107cbbef]
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers [clinicaltrials:NCT00005570]Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura [clinicaltrials:NCT00005652]Efficacy and Safety of IVIG-L in ITP Patients [clinicaltrials:NCT00151840]clinicaltrials:NCT00220727Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment [clinicaltrials:NCT00359463]clinicaltrials:NCT00370331clinicaltrials:NCT00372892Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00441090]Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment [clinicaltrials:NCT00442871]Eltrombopag Taste Testing in Healthy Adult Volunteers [clinicaltrials:NCT00487968]clinicaltrials:NCT00540423Study of Veltuzumab (hA20) at Different Doses in Patients With ITP [clinicaltrials:NCT00547066]Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag [clinicaltrials:NCT00688272]clinicaltrials:NCT00706342clinicaltrials:NCT00828750Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect [clinicaltrials:NCT01072162]The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. [clinicaltrials:NCT01101295]Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia [clinicaltrials:NCT01317966]Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects [clinicaltrials:NCT01327872]clinicaltrials:NCT01356511"End of EXTEND: Observing for Cure in Patients With Chronic ITP" [clinicaltrials:NCT01386723]clinicaltrials:NCT01610180Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). [clinicaltrials:NCT02009761]A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT02201290]Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects [clinicaltrials:NCT02281370]Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia [clinicaltrials:NCT02334813]A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients [clinicaltrials:NCT02403440]
condition [clinicaltrials_vocabulary:condition]
Treatment of Autoimmune Thrombocytopenia (AITP) [clinicaltrials:NCT00001630]A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura [clinicaltrials:NCT00002250]An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers [clinicaltrials:NCT00005570]Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura [clinicaltrials:NCT00005652]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Daclizumab to Treat Chronic Immune Thrombocytopenia [clinicaltrials:NCT00049725]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [clinicaltrials:NCT00102323]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [clinicaltrials:NCT00102336]SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00102739]Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00107913]Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP) [clinicaltrials:NCT00111475]clinicaltrials:NCT00116688Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00117143]Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D [clinicaltrials:NCT00128882]Efficacy and Safety of IVIG-L in ITP Patients [clinicaltrials:NCT00151840]Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders [clinicaltrials:NCT00157079]A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone [clinicaltrials:NCT00161564]Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00162006]clinicaltrials:NCT00168038clinicaltrials:NCT00220727Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy [clinicaltrials:NCT00225875]Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00244257]Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire [clinicaltrials:NCT00331357]clinicaltrials:NCT00344149EXTEND (Eltrombopag Extended Dosing Study) [clinicaltrials:NCT00351468]Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment [clinicaltrials:NCT00359463]Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients [clinicaltrials:NCT00362349]clinicaltrials:NCT00370331clinicaltrials:NCT00372892clinicaltrials:NCT00376077clinicaltrials:NCT00392951clinicaltrials:NCT00415532clinicaltrials:NCT00424177clinicaltrials:NCT00426270Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00441090]Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment [clinicaltrials:NCT00442871]High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP [clinicaltrials:NCT00451594]clinicaltrials:NCT00454857Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00467571]clinicaltrials:NCT00475423
condition browse [clinicaltrials_vocabulary:condition-browse]
Treatment of Autoimmune Thrombocytopenia (AITP) [clinicaltrials:NCT00001630]A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura [clinicaltrials:NCT00002250]An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers [clinicaltrials:NCT00005570]Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura [clinicaltrials:NCT00005652]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Daclizumab to Treat Chronic Immune Thrombocytopenia [clinicaltrials:NCT00049725]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [clinicaltrials:NCT00102323]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [clinicaltrials:NCT00102336]SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00102739]Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00107913]Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP) [clinicaltrials:NCT00111475]clinicaltrials:NCT00116688Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00117143]Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D [clinicaltrials:NCT00128882]Efficacy and Safety of IVIG-L in ITP Patients [clinicaltrials:NCT00151840]Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders [clinicaltrials:NCT00157079]A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone [clinicaltrials:NCT00161564]Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00162006]clinicaltrials:NCT00168038clinicaltrials:NCT00220727Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy [clinicaltrials:NCT00225875]Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00244257]Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire [clinicaltrials:NCT00331357]clinicaltrials:NCT00344149EXTEND (Eltrombopag Extended Dosing Study) [clinicaltrials:NCT00351468]Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment [clinicaltrials:NCT00359463]Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients [clinicaltrials:NCT00362349]clinicaltrials:NCT00370331clinicaltrials:NCT00372892clinicaltrials:NCT00376077clinicaltrials:NCT00392951clinicaltrials:NCT00415532clinicaltrials:NCT00424177clinicaltrials:NCT00426270Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00441090]Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment [clinicaltrials:NCT00442871]High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP [clinicaltrials:NCT00451594]clinicaltrials:NCT00454857Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00467571]clinicaltrials:NCT00475423
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Purpura, Thrombocytopenic, Idiopathic [clinicaltrials_resource:8fd5b4539415edc1fbd6361e107cbbef]
Bio2RDF identifier
8fd5b4539415edc1fbd6361e107cbbef
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8fd5b4539415edc1fbd6361e107cbbef
identifier
clinicaltrials_resource:8fd5b4539415edc1fbd6361e107cbbef
title
Purpura, Thrombocytopenic, Idiopathic
@en
type
label
Purpura, Thrombocytopenic, Idi ...... 5b4539415edc1fbd6361e107cbbef]
@en
Purpura, Thrombocytopenic, Idiopathic